FisherVista

Premier Graphene Inc. successfully delivered its first military order to Mexico's SEDENA, positioning the company for expanded defense contracts across Latin America.

Qdrant's vector search technology enables Sapu's AI platform to index and query all 28 million PubMed abstracts, accelerating biomedical discovery for cancer research.

American Shared Hospital Services (NYSE American: AMS) will release its first quarter 2026 financial results before market open on May 14, followed by a conference call at 12:00 PM ET, providing investors with insight into the company's performance and outlook.

Auddia showcases Influence Healthcare, a healthtech platform using AI and vertical integration to empower surgeon-led value-based care, as it prepares to file its S-4 registration for the merger forming McCarthy Finney.

Aemetis reported first quarter 2026 revenues of $54.6 million, a 27% increase year-over-year, with gross profit turning positive and dairy RNG sales volume growing 55%, highlighting the impact of operational scale and new production tax credits.

Aclarion has enrolled Lanman Spinal Neurosurgery in its CLARITY trial, expanding Nociscan's evaluation to private practice settings and aiming to improve surgical outcomes for chronic low back pain.

SS Innovations International demonstrated long-distance telesurgery at the Royal Australian College of Surgeons Congress, performing a robotic procedure on a patient in India from Perth, Australia, highlighting the potential to democratize global surgical access.

A systematic review in JAMA Network Open suggests that earlier administration of immune checkpoint inhibitors may improve survival outcomes in patients with late-stage solid tumors, with implications for companies like Calidi Biotherapeutics.

Apple has agreed to a $250 million settlement in a U.S. lawsuit alleging it misled customers about the capabilities and availability of its Apple Intelligence AI features for iPhones.

SKYX Platforms Corp. announced record Q1 2026 revenue of $22 million, a 10% year-over-year increase, driven by strategic partnerships in Europe and the U.S., positioning the company for cash flow positivity by year-end.

Oregen Energy Corp. has appointed Philip Birch, a petroleum geoscientist who played a key role in the Venus discovery, as strategic advisor to evaluate a potential investment in Namibia's offshore Block 2812Ab adjacent to the Venus prospect.

Planet Ventures Inc. is positioning itself in the emerging orbital power race, recognizing that scalable energy infrastructure in space is becoming a critical constraint as satellite networks and AI workloads expand.

SureNano Science has begun a GLP toxicology and pharmacology program for its lead candidate GEP-44, aiming to enter the $200 billion GLP-1 market with a multi-receptor peptide targeting obesity and type 2 diabetes.

Oncotelic Therapeutics is using a partnership-driven strategy, including a GMP Bio joint venture that added $249 million to its balance sheet, to advance its drug pipeline and AI platform without diluting shareholder value.

Greenland Energy Company is focusing on Greenland’s Jameson Land Basin to unlock new hydrocarbon resources amid global supply disruptions and reserve depletion.